{"id":188647,"date":"2026-02-18T17:24:00","date_gmt":"2026-02-18T22:24:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/02\/18\/drugmakers-turn-to-ai-to-speed-trials-regulatory-submissions\/"},"modified":"2026-02-18T17:30:14","modified_gmt":"2026-02-18T22:30:14","slug":"drugmakers-turn-to-ai-to-speed-trials-regulatory-submissions","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/02\/18\/drugmakers-turn-to-ai-to-speed-trials-regulatory-submissions\/","title":{"rendered":"Drugmakers turn to AI to speed trials, regulatory submissions"},"content":{"rendered":"<p><a href=\"https:\/\/www.aol.com\/drugmakers-turn-ai-speed-trials-110213746.html?utm_sourceu003dflipboardu0026utm_contentu003dAOLcom\/magazine\/Business\">Drugmakers turn to AI to speed trials, regulatory submissions<\/a><\/p>\n<p><a href=\"https:\/\/www.aol.com\/drugmakers-turn-ai-speed-trials-110213746.html?utm_sourceu003dflipboardu0026utm_contentu003dAOLcom\/magazine\/Business\">https:\/\/www.aol.com\/drugmakers-turn-ai-speed-trials-110213746.html?utm_sourceu003dflipboardu0026utm_contentu003dAOLcom\/magazine\/Business<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-02-18 17:24:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.aol.com\">www.aol.com<\/a><\/p>\n<ul>\n<li><strong>AI Streamlines Drug Development<\/strong>: AI is significantly improving the efficiency of less glamorous, labor-intensive tasks in drug development such as finding clinical trial participants and sites, and drafting regulatory documents.<\/li>\n<li><strong>Speeding Up Clinical Trials<\/strong>: Firms like Novartis have reported using AI to drastically reduce the time needed for site selection and participant enrollment, thereby accelerating the clinical trial process.<\/li>\n<li><strong>Potential Cost Savings and Increased Efficiency<\/strong>: McKinsey estimates AI could increase clinical development productivity by 35% to 45% over the next five years. GSK reports saving millions in costs by using AI to cut down on manual data collection.<\/li>\n<li><strong>Use Cases and Developments<\/strong>: Novartis, GSK, Genmab, and ITM are specifically employing AI for tasks like site selection, trial enrollment, manual data collection reduction, and converting clinical trial reports into FDA-compliant formats.<\/li>\n<li><strong>Emerging AI Tools and Focus Areas<\/strong>: AI is being applied to enhance administrative tasks, improve patient outreach and scheduling, and potentially lead to faster development of new drugs, though the full impact on drug discovery is still emerging.<\/li>\n<li><strong>Industry-Wide Adoption and Future Prospects<\/strong>: The pharmaceutical sector, including major players and emerging firms, is fervently investing in AI tools, underscoring its transformative potential, which could revolutionize drug development as seen in the technological upheaval akin to the internet era.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drugmakers turn to AI to speed trials, regulatory submissions https:\/\/www.aol.com\/drugmakers-turn-ai-speed-trials-110213746.html?utm_sourceu003dflipboardu0026utm_contentu003dAOLcom\/magazine\/Business Publish Date: 2026-02-18 17:24:00 Source&#8230;<\/p>\n","protected":false},"author":1,"featured_media":188648,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/s.yimg.com\/cv\/apiv2\/aolfp\/images\/og-image.png","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-188647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/188647"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=188647"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/188647\/revisions"}],"predecessor-version":[{"id":188649,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/188647\/revisions\/188649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/188648"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=188647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=188647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=188647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}